Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region

Hsueh, Po-Ren; Hoban, Daryl J.; Carmeli, Yehuda; Chen, Shey-Ying; Desikan, Sunita; Alejandria, Marissa; Ko, Wen Chien; Bình, Trần Quang

doi:10.1016/j.jinf.2011.05.015

Cited by 132 publications

(80 citation statements)

References 32 publications

(37 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In our study population, E. coli ESBL had a prevalence of 9% (Table 1), which is in line with the rate in many countries in Central Europe, and the resulting total error rate for all E. coli isolates with respect to amoxicillinclavulanic acid was 2.5% (Table 1) (42). If the ESBL prevalence were as high as 60%, as reported for many regions in Asia, the total error rate would increase to 4.8% (43).…”

Section: Discussionmentioning

confidence: 91%

Integrating Forecast Probabilities in Antibiograms: a Way To Guide Antimicrobial Prescriptions More Reliably?

Maurer¹,

Courvalin²,

Böttger³

et al. 2014

J Clin Microbiol

View full text Add to dashboard Cite

bAntimicrobial susceptibility testing (AST) assigns pathogens to "susceptible" or "resistant" clinical categories based on clinical breakpoints (CBPs) derived from MICs or inhibition zone diameters and indicates the likelihood for therapeutic success. AST reports do not provide quantitative measures for the reliability of such categorization. Thus, it is currently impossible for clinicians to estimate the technical forecast uncertainty of an AST result regarding clinical categorization. AST error rates depend on the localization of pathogen populations in relation to CBPs. Bacterial species are, however, not homogeneous, and subpopulations behave differently with respect to AST results. We addressed how AST reporting errors differ between isolates with and without acquired drug resistance determinants. Using as an example the beta-lactams and their most important resistance mechanisms, we analyzed different pathogen populations for their individual reporting error probabilities. Categorization error rates were significantly higher for bacterial populations harboring resistance mechanisms than for the wild-type population. Reporting errors for amoxicillin-clavulanic acid and piperacillin-tazobactam in Escherichia coli infection cases were almost exclusively due to the presence of broad-spectrum-and extended-spectrum-beta-lactamase (ESBL)-producing microorganisms (79% and 20% of all errors, respectively). Clinicians should be aware of the significantly increased risk of erroneous AST reports for isolates producing beta-lactamases, particularly ESBL and AmpC. Including probability indicators for interpretation would improve AST reports.

show abstract

Section: Discussionmentioning

confidence: 91%

Integrating Forecast Probabilities in Antibiograms: a Way To Guide Antimicrobial Prescriptions More Reliably?

Maurer¹,

Courvalin²,

Böttger³

et al. 2014

J Clin Microbiol

View full text Add to dashboard Cite

show abstract

“…Other data have shown that ESBL-producing E. coli are found to be the highest, 60% in India (Hsueh et al, 2011) and 57.8% in Israel (Colodner et al, 2004), followed by Hong Kong (48%) and Singapore (33%) (Hsueh et al, 2011).…”

Section: Discussionmentioning

confidence: 92%

Antimicrobial resistance in extended spectrum -lactamases (ESBL)-producing Escherichia coli isolated from human urinary tract infections in Ndjamena, Chad

Ndoutamia¹,

Yandai²,

Nadlaou³

2015

Afr. J. Microbiol. Res.

View full text Add to dashboard Cite

“…Pathogenic microorganisms isolated from diarrhea patients are bacterial in approximately 80 of cases, with E. coli and Shigella being characteristic examples (5). Recently, extendedspectrum beta-lactamase (ESBL)-producing antibioticresistant strains, especially E. coli strains, have been in-creasingly reported in fecal samples, and the proportion of ESBL-producing strains in all E. coli has increased to 8-10 in European, Asian, and North American countries (6)(7)(8). ESBLs are class A beta-lactamases with a plasmid-related resistance mechanism; they are categorized into TEM-and SHV-types derived from the natural narrow-spectrum enzymes (9,10) and a CTX-M-type derived from beta-lactamase on the Kluyvera chromosome (11).…”

Section: Introductionmentioning

confidence: 99%

Antibiotic Susceptibilities and Genetic Characteristics of Extended-Spectrum Beta-Lactamase-Producing <i>Escherichia coli</i> Isolates from Stools of Pediatric Diarrhea Patients in Surabaya, Indonesia

et al. 2017

View full text Add to dashboard Cite

Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region

Cited by 132 publications

References 32 publications

Integrating Forecast Probabilities in Antibiograms: a Way To Guide Antimicrobial Prescriptions More Reliably?

Integrating Forecast Probabilities in Antibiograms: a Way To Guide Antimicrobial Prescriptions More Reliably?

Antimicrobial resistance in extended spectrum -lactamases (ESBL)-producing Escherichia coli isolated from human urinary tract infections in Ndjamena, Chad

Antibiotic Susceptibilities and Genetic Characteristics of Extended-Spectrum Beta-Lactamase-Producing <i>Escherichia coli</i> Isolates from Stools of Pediatric Diarrhea Patients in Surabaya, Indonesia

Contact Info

Product

Resources

About